← ANALYST RATINGS · TIPRANKS
Ceribell, Inc. (CBLL): analyst forecast and price target
Analyst consensus
Strong Buy6 Buy0 Hold0 Sell
Ratings of 6 analysts in the last 3 months12-month forecast
Based on 6 price targets given in the last 3 months, the average target is $29.50, the highest $33.00, the lowest $26.00. The average is +17.8% from the last price of $25.04.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $28.00 → $26.00−7.1% | Hold | +3.8% | Reiterated | 17.10.26on TipRanks 10:06 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $26.00 → $25.00−3.8% | Hold | −0.2% | Reiterated | 17.10.26on TipRanks 10:06 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $27.00 → $26.00−3.7% | Hold | +3.8% | Reiterated | 17.10.26on TipRanks 10:06 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $26.00 → $25.00−3.8% | Hold | −0.2% | Reiterated | 17.10.26on TipRanks 10:06 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $28.00 → $27.00−3.6% | Hold | +7.8% | Reiterated | 17.10.26on TipRanks 10:06 | — | |
| Josh Jennings★★★★★★★★★★#3537 · hits 46% · avg +3.0% | TD Cowen | $29.00 → $33.00+13.8% | Buy | +31.8% | Reiterated | 02.10.26on TipRanks 01:30 | −0.4%next day +4.3% · 5 days −1.4% | ↗ |
| Brandon Vazquez★★★★★★★★★★#11688 · hits 42% · avg −5.1% | William Blair | — | Buy | — | Reiterated | 30.09.26on TipRanks 15:06 | −1.7%next day −3.4% · 5 days −5.6% | ↗ |
| Marie Thibault★★★★★★★★★★#12343 · hits 40% · avg −9.7% | BTIG | $30.00 | Buy | +19.8% | Reiterated | 21.09.26on TipRanks 08:15 | −2.0%next day 0.0% · 5 days +2.1% | ↗ |
| Unknown Analyst | Raymond James | $29.00 | Buy | +15.8% | Reiterated | 03.09.26on TipRanks Sep 4 04:45 | −2.0%next day +1.0% · 5 days −2.7% | ↗ |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $19.50 → $26.00+33.3% | Hold | +3.8% | Reiterated | 19.08.26on TipRanks 14:05 | — | |
| William Plovanic★★★★★★★★★★#5377 · hits 43% · avg +1.3% | Canaccord Genuity | $26.00 | Buy | +3.8% | Reiterated | 13.08.26on TipRanks Aug 11 07:05 | +10.7%next day +7.3% · 5 days +14.0% | ↗ |
| Travis Steed★★★★★★★★★★#3596 · hits 53% · avg +3.0% | Bank of America Securities | — | Buy | — | Reiterated | 11.08.26on TipRanks 11:05 | +10.7%next day +7.3% · 5 days +14.0% | ↗ |
| Jeffrey Cohen★★★★★★★★★★#11115 · hits 35% · avg −2.9% | Ladenburg Thalmann & Co. | $32.00 | Buy | +27.8% | Reiterated | 12.05.26on TipRanks May 13 05:15 | −16.3%next day +6.4% · 5 days +1.9% | ↗ |
| Robbie Marcus★★★★★★★★★★#1974 · hits 51% · avg +6.5% | J.P. Morgan | $17.00 | Buy | −32.1% | Reiterated | 05.11.25on TipRanks 08:30 | +7.5%next day −0.8% · 5 days +8.2% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Ceribell, Inc.
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $28.50 at a price of $24.39 (+16.9%); now: $29.50 at $25.04 (+17.8%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 2 | 1 | 1 |
| Buy | 7 | 8 | 6 | 8 | 11 | 12 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 17.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-0.51 (from $-0.55 to $-0.45). Last quarter: $-0.51.
Sales
Next quarter’s sales estimate — $29M (from $29M to $30M). Last quarter: $28M.
Best top-analyst consensus in the sector · General
About Ceribell, Inc.
- CEO: Xingjuan Chao
- Employees: 327
- 360 North Pastoria Avenue, Sunnyvale, CA, 94085, US
- ceribell.com
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
Data from the stock’s TipRanks forecast page, read 33 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗